Volume 9, Number 12—December 2003
Research
Multidrug-resistant Mycobacterium tuberculosis in HIV-Infected Persons, Peru
Table 4
Hospital | No. AIDS patients reported during 1999c | No. TB patients diagnosed during 1999 | Total no. HIV-infected patients with a new diagnosis of TB | No. (%) HIV-infected patients with a new diagnosis of TB interviewed | No. MDR-TB ÷ total drug susceptibility test results available (%) | |
---|---|---|---|---|---|---|
A |
154 |
1,985 |
204 |
116 (57) |
28/52 (54) |
|
B |
60 |
723 |
49 |
40 (82) |
4/9 (44) |
|
C |
139 |
1,068 |
41 |
24 (59) |
2/7 (29) |
|
D |
10 |
891 |
37 |
29 (78) |
0/4 (0) |
|
E |
33 |
635 |
33 |
21 (64) |
0/5 (0) |
|
F |
95 |
608 |
29 |
11 (38) |
0/1 (0) |
|
G |
9 |
425 |
12 |
11 (92) |
0/1 (0) |
|
H |
30 |
169 |
6 |
4 (67) |
0/1 (0) |
|
I |
4 |
130 |
3 |
1 (33) |
0/0 (NA) |
|
J |
2 |
131 |
1 |
1 (100) |
1/1 (100) |
|
Total | 554 | 6,765 | 415 | 258 | 35/81 (43) |
aAmong those co-infected with TB and HIV, the number (%) with MDR-TB.
bMDR-TB; multidrug-resistant tuberculosis.
cNumber of AIDS cases reported to the National AIDS and STD Control Program.
Page created: February 07, 2011
Page updated: February 07, 2011
Page reviewed: February 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.